This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Hildegund C. J. Ertl is a researcher who works at The Wistar Institute in Philadelphia.[1]
Career
editErtl's research into vaccine has taken a different approach from conventional wisdom, combining parts of different viruses that pose no harm to humans but still stimulate an immune response.[2]
In 2007, Ertl helped create The Wistar Institute Vaccine Center. Ertl said that the vaccines the laboratories in the center are developing "have important implications for public health because they can reduce disease and death from very common infections.[3] Additionally, she said that she wants to make existing vaccines more accessible in developing areas such as Africa and Asia.[4]
In interviews, Ertl has been cautious and critical when it comes to the development of vaccines for AIDS. Her research has shown that the vaccine may exhaust key cells of the immune system that are needed to fight the virus.[5]
References
edit- ^ "Hildegund C.J. Ertl, M.D." The Wistar Institute. Retrieved 12 February 2014.
- ^ "Building a better vaccine Hildegund Ertl and her Philadelphia researchers pursue a new way to conquer the AIDS virus, threats from bioterrorism and other stubborn, deadly diseases". philly.com. Archived from the original on October 13, 2013. Retrieved 12 February 2014.
- ^ "Wistar spinout raises $5 million". www.bizjournals.com. Philadelphia Business Journal.
- ^ "The Wistar Institute Launches New Vaccine Center". The Wistar Institute. Retrieved 12 February 2014.
- ^ "Study shows how some AIDS vaccines may harm". Reuters. 17 November 2007. Retrieved 12 February 2014.
External links
edit
This article needs additional or more specific categories. (March 2023) |